ImmunoGen
IMGN
#2144
Rank
NZ$15.10 B
Marketcap
NZ$54.06
Share price
0.00%
Change (1 day)
138.37%
Change (1 year)

ImmunoGen (IMGN) - Cash on Hand

Cash on Hand as of September 2023 : NZ$1.04 Billion

According to ImmunoGen 's latest financial reports the company has NZ$1.04 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ImmunoGen - Cash on Hand chart (from 1996 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.43 B-38.17%
2021-12-31NZ$0.70 B72.1%
2020-12-31NZ$0.40 B55.64%
2019-12-31NZ$0.26 B-33.07%
2018-12-31NZ$0.39 B3.95%
2017-12-31NZ$0.37 B
2016-06-30NZ$0.34 B-16.21%
2015-06-30NZ$0.40 B152.4%
2014-06-30NZ$0.16 B-35.57%
2013-06-30NZ$0.25 B25.64%
2012-06-30NZ$0.20 B-13.12%
2011-06-30NZ$0.23 B44.76%
2010-06-30NZ$0.15 B43.73%
2009-06-30NZ$0.11 B76.31%
2008-06-30NZ$62.92 M-18.97%
2007-06-30NZ$77.65 M-37.31%
2006-06-30NZ$0.12 B-6.45%
2005-06-30NZ$0.13 B-10.49%
2004-06-30NZ$0.14 B-14.96%
2003-06-30NZ$0.17 B-38.67%
2002-06-30NZ$0.28 B22.02%
2001-06-30NZ$0.23 B530.21%
2000-06-30NZ$36.88 M261.6%
1999-06-30NZ$10.19 M211.99%
1998-06-30NZ$3.26 M30.58%
1997-06-30NZ$2.5 M-38.78%
1996-06-30NZ$4.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Seagen
SGEN
NZ$2.14 B 104.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.34 B 1,459.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$17.16 B 1,537.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$28.56 B 2,625.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$32.13 B 2,965.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$25.93 B 2,374.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$16.88 B 1,510.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$18.09 B 1,626.06%๐Ÿ‡ซ๐Ÿ‡ท France